Back to search

France· FR:68737947

ACIDE ZOLEDRONIQUE HOSPIRA 4 mg/100 ml, solution pour perfusion

A medicinal product, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedACIDE ZOLEDRONIQUE HOSPIRA 4 mg/100 m…ATC—REGISTER NO.FR:68737947PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
PFIZER EUROPE MA EEIG (BELGIQUE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400926878344
    1 poche(s) polypropylène de 100 ml
    EUR 98.27

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ACIDE in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ACIDE products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
  • Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
  • Cyprus · Nordeloz, Zoledronic Acid Altan
  • Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
  • Germany · Aszora, Clastizol
  • Denmark · Zoledo, Zoledronsyre Fresenius Kabi
  • Estonia · Zoledronic Acid Fresenius Kabi
  • Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Finland · Zobiore, Zoledronic Acid Fresenius Kabi
  • United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
  • Greece · Bonevin, Nordeloz
  • Croatia · Zolenat
  • Hungary · Osporil, Zoledronsav Fresenius Kabi
  • Ireland · Zerlinda, Zoledronic Acid
  • Iceland · Aclasta, Aszora
  • Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
  • Liechtenstein · Aclasta, Zoledronic Acid Accord
  • Lithuania · Zoledronic Acid Fresenius Kabi
  • Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Latvia · Zoledronic Acid Fresenius Kabi
  • Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
  • Norway · Aclasta, Zoledo
  • Poland · Osporil, Zerlinda
  • Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
  • Sweden · Zerlinda, Zoledronic Acid Accord
  • Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
  • Slovakia · Kyselina, Kyselina Zoledrónová Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fdc2b600-2bbb-4cb1-a27a-8d4d3c8bbdae
GET /v1/drugs/fdc2b600-2bbb-4cb1-a27a-8d4d3c8bbdae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68737947",
  "date_amm": "2012-11-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/12/800",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ACIDE.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.